Multiple Sclerosis

The AJMC® Multiple Sclerosis compendium is a comprehensive resource for clinical news and expert insights for the disabling disease that impacts the brain and spinal cord.

Latest News

Doctor examining MRI images of multiple sclerosis MS | Image Credit: © New Africa - stock.adobe.com
Lesion Repair, Damage Processes Correlate With MS Disease Characteristics

November 11th 2024

New data suggest the frequency of damage and repair processes correlates with disease severity and disability in multiple sclerosis (MS).

Neurologic disease concept | image credit: ralwel - stock.adobe.com
Fexagratinib in MS Shows Promise for Human Use

November 9th 2024

MS word cloud | Image Credit: © arloo-stock.adobe.com
Exploring Metabolic Links to Cognitive Impairment in MS

November 8th 2024

Fingolimod | Image Credit: © María Pilar Martínez - stock.adobe.com
Fingolimod-Induced Heart Rate Slowing Tied to Parasympathetic Dominance in MS

October 26th 2024

MRI head brain scan | Image Credit: © DedMityay - stock.adobe.com
Brain Volume Loss Reductions Offer Comparative Tool for DMTs in Relapsing MS

October 24th 2024

Examining the Role of a Novel Class of Medications for the Management of Multiple Sclerosis

This video series provides an in-depth look at multiple sclerosis, covering its impact, pathophysiology, treatment strategies, unmet needs, patient satisfaction, and future research. Gain key insights into managing and understanding this condition.

This video series provides an in-depth look at multiple sclerosis, covering its impact, pathophysiology, treatment strategies, unmet needs, patient satisfaction, and future research. Gain valuable insights into managing and understanding this complex condition.
Continuing Medical Education
View All
November 21st 2024

Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care

1.5 Credits / Neurology
November 21st 2024

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

1.5 Credits / Cardiology, Neurology, Rare Diseases
November 21st 2024

The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of Early Intervention, Patient-Centered Care, and Disease-Modifying Therapies in Slowing Disease Progression

1.0 Credit / Neurology
November 21st 2024

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

1.0 Credit / Immunology, Neurology
November 21st 2024

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

More News

Dr Marie D'hooghe Discusses How Pregnancy Affects Disease Course in Patients With MS
September 11th 2019

Dr Marie D'hooghe Discusses How Pregnancy Affects Disease Course in Patients With MS

Some data suggest that pregnancy may be beneficial in the long-term for patients with multiple sclerosis (MS), but there exist periods that may carry an extra risk of relapse, such as before conception and in the postpartum period, according to Marie D’hooghe, MD, PhD, neurologist at the National MS Center, Melsbroek, in Brussels, Belgium, and consultant neurologist at the University Hospital in Brussels, Belgium.
Dr Daniel Kantor Explains How MS Measurement and Prediction Can Lead to Precision Medicine
September 10th 2019

Dr Daniel Kantor Explains How MS Measurement and Prediction Can Lead to Precision Medicine

Using imaging, laboratory testing, and predictive models, the field of multiple sclerosis (MS) is getting closer to predicting the course of MS and, eventually, the best medication for a given patient, said Daniel Kantor, MD, president of Kantor Neurology.
Studies Support Use of Oral Ozanimod to Treat Relapsing Multiple Sclerosis
September 10th 2019

Studies Support Use of Oral Ozanimod to Treat Relapsing Multiple Sclerosis

Laura Joszt, MA
In 2 studies published in The Lancet Neurology, ozanimod was well tolerated and had a lower relapse rate in patients with relapsing multiple sclerosis.
Dr Daniel Kantor Highlights MS Treatments and What Is in the Pipeline
September 7th 2019

Dr Daniel Kantor Highlights MS Treatments and What Is in the Pipeline

The field of treatments for multiple sclerosis (MS) has grown quickly in the last 30 years, but the next new class of therapies probably won’t come to market for at least another year and a half, said Daniel Kantor, MD, president of Kantor Neurology.
Guideline Update Emphasizes Importance of Vaccinations for Patients With MS
September 4th 2019

Guideline Update Emphasizes Importance of Vaccinations for Patients With MS

Christina Mattina
A guideline update issued by the American Academy of Neurology states that patients with multiple sclerosis (MS) should receive all recommended vaccinations unless contraindicated.
This Week in Managed Care: August 30, 2019
August 30th 2019

This Week in Managed Care: August 30, 2019

This week, the top managed care stories included a huge ruling against one opioid maker and a settlement offer from another; an expert panel calling for broader screening for hepatitis C; a review showing there are more fatal events linked to a multiple sclerosis drug than previously known.
Dr Patty Taddei-Allen: Feedback From Patient-Reported Outcomes Can Help Achieve Better Quality of Life
August 28th 2019

Dr Patty Taddei-Allen: Feedback From Patient-Reported Outcomes Can Help Achieve Better Quality of Life

Understanding patient-reported outcomes in disease states enhances our ability to provide patients with better care and an increased quality of life, said Patty Taddei-Allen, PharmD, MBA, BCACP, BCGP, director of outcomes research, WelldyneRx.
Despite More Competition, Medicare Costs for MS Drugs Rose Steadily Over 10 Years
August 27th 2019

Despite More Competition, Medicare Costs for MS Drugs Rose Steadily Over 10 Years

Laura Joszt, MA
Even as more competition entered the market, the prices of self-administered disease-modifying therapies for multiple sclerosis (MS) rose steadily from 2006 to 2016, and seniors with Medicare Part D coverage saw a 7.2-fold increase in out-of-pocket costs.
Fatal AEs Associated With Alemtuzumab for MS May Occur More Frequently Than Previously Thought
August 23rd 2019

Fatal AEs Associated With Alemtuzumab for MS May Occur More Frequently Than Previously Thought

Laura Joszt, MA
Fatal adverse events (AEs) associated with alemtuzumab for multiple sclerosis (MS) may occur more frequently than previously understood based on past published literature, researchers found.
June Halper Describes the Team-Based Approach Underlying the Consortium of MS Centers
August 23rd 2019

June Halper Describes the Team-Based Approach Underlying the Consortium of MS Centers

The Consortium of Multiple Sclerosis (MS) Centers is unique in that it places physicians and other healthcare professionals on a level playing field while elevating the patient’s voice to be the most important on the team, explained June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers.
June Halper on How Supportive Team Care Can Help Patients With MS as Their Disability Increases
August 15th 2019

June Halper on How Supportive Team Care Can Help Patients With MS as Their Disability Increases

While there may be negative connotations attached to the term “palliative care,” this type of care could be called “supportive team care” to better express its potential to educate and care for patients with chronic illnesses such as multiple sclerosis (MS), said June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers.
Chronic Active Lesions Associated With Poorer Outcomes in Multiple Sclerosis
August 14th 2019

Chronic Active Lesions Associated With Poorer Outcomes in Multiple Sclerosis

Laura Joszt, MA
Chronic active lesions, which are identified by their darkened outer rims, are associated with more aggressive multiple sclerosis and earlier disability, according to new research from the National Institute of Health.
Patients With MS Less Likely to Have Received Vaccinations Before MS Diagnosis
August 9th 2019

Patients With MS Less Likely to Have Received Vaccinations Before MS Diagnosis

Laura Joszt, MA
In the 5 years before being diagnosed, patients with multiple sclerosis (MS) were less likely to receive vaccinations than comparator groups, according to a new study from the Technical University of Munich and published in Neurology.
AJMC® in the Press, August 9, 2019
August 9th 2019

AJMC® in the Press, August 9, 2019

AJMC Staff
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
June Halper Discusses the Importance of Shared Decision Making in MS Treatment
August 8th 2019

June Halper Discusses the Importance of Shared Decision Making in MS Treatment

Shared decision making has been taught to clinicians for years, but it is especially crucial when treating multiple sclerosis (MS) due to the importance of treatment adherence, according to June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers.
Researchers Identify Cell That Causes Brain Shrinkage in Multiple Sclerosis
August 2nd 2019

Researchers Identify Cell That Causes Brain Shrinkage in Multiple Sclerosis

Laura Joszt, MA
The brain shrinkage that occurs in patients with multiple sclerosis may be the result of a specific brain cell: When projection neurons are damaged, the brain shrinks.
Dr Patty Taddei-Allen Outlines the Importance of Adherence to MS Therapies
August 1st 2019

Dr Patty Taddei-Allen Outlines the Importance of Adherence to MS Therapies

Encouraging patient adherence to medication is very important to managing the cost of multiple sclerosis (MS) therapies, said Patty Taddei-Allen, PharmD, MBA, BCACP, BCGP, director, outcomes research, WelldyneRx.
Site Logo
July 31st 2019

Contemporary Management of Multiple Sclerosis: A Stakeholder Interchange Report

June Halper: The Role of Caregiver in MS Is Extremely Important
July 26th 2019

June Halper: The Role of Caregiver in MS Is Extremely Important

Since multiple sclerosis is a chronic disease with no cure or control, the role of a caregiver or care partner is very important, said June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers.
Physical Disability, Executive Functioning Predict Employment Status in Patients With MS
July 24th 2019

Physical Disability, Executive Functioning Predict Employment Status in Patients With MS

Christina Mattina
The likelihood of patients with multiple sclerosis (MS) maintaining their employment status in 2 years can be predicted by their levels of physical disability and executive functioning, but not by other measures of cognition, according to new study findings.
Site Logo
July 23rd 2019

CMSC Partners With FCMSC to Launch Mental Health Mentorship Program

The Consortium of Multiple Sclerosis Centers (CMSC) is teaming up with the Foundation of the CMSC and EMD Serono to launch a new Mental Health Mini Mentorship Program this summer.
June Halper Emphasizes the Lack of Understanding of Causes of Multiple Sclerosis
July 17th 2019

June Halper Emphasizes the Lack of Understanding of Causes of Multiple Sclerosis

The cause of multiple sclerosis is not well understood. In fact, it’s not understood at all, explained June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers.
Obesity Associated With Increased Risk of Pediatric MS, Poor Response to Treatment
July 16th 2019

Obesity Associated With Increased Risk of Pediatric MS, Poor Response to Treatment

Laura Joszt, MA
Patients with obesity not only have a higher risk of pediatric multiple sclerosis (MS), but they also do not respond as well to first-line medications.
A Diet Rich in Fruit and Vegetables Could Help Improve Multiple Sclerosis Fatigue
July 13th 2019

A Diet Rich in Fruit and Vegetables Could Help Improve Multiple Sclerosis Fatigue

Sara Karlovitch
A new study suggests lipid profiles could help improve multiple sclerosis (MS) fatigue.
June Halper on Challenges With Identifying Which Multiple Sclerosis Treatments Have the Most Promise
July 9th 2019

June Halper on Challenges With Identifying Which Multiple Sclerosis Treatments Have the Most Promise

Identifying which treatments for multiple sclerosis have the most promise is challenging because there are no head-to-head studies comparing treatments and what's promising for one clinician is different than what's promising for another clinician, explained June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers.
Dr Mark Freedman Outlines the Precision Decision in Multiple Sclerosis Treatments
July 3rd 2019

Dr Mark Freedman Outlines the Precision Decision in Multiple Sclerosis Treatments

There are a lot of factors that should be considered when choosing a therapy for a patient with multiple sclerosis, including the patient profile, the patient’s lifestyle, and the efficacy of the therapy, said Mark Freedman, MD, MSc, professor of medicine in neurology at the University of Ottawa, director of the Multiple Sclerosis Research Unit, at Ottawa Hospital-General Campus, and senior scientists in the neuroscience program at Ottawa Hospital Research Institute.
Multiple Sclerosis Remains Tricky to Identify, Diagnose
July 3rd 2019

Multiple Sclerosis Remains Tricky to Identify, Diagnose

Sara Karlovitch
Two abstracts presented at the American Academy of Neurology 2019 Annual Meeting evaluated misdiagnosis of multiple sclerosis.
Multiple Sclerosis Patients Face a Staggering Economic Burden, Even With Low Physical Disability
June 28th 2019

Multiple Sclerosis Patients Face a Staggering Economic Burden, Even With Low Physical Disability

Wallace Stephens
Regardless of their level of disabilty, patients with multiple sclerosis face a substantial financial burden.
Pediatric-Onset MS Associated With Higher Risk of Cognitive Impairment Than Adult-Onset MS
June 23rd 2019

Pediatric-Onset MS Associated With Higher Risk of Cognitive Impairment Than Adult-Onset MS

Laura Joszt, MA
Patients with pediatric-onset multiple sclerosis (MS) not only have lower cognitive scores in adulthood than patients with adult-onset MS, but cognitive scores declined faster.
June Halper Outlines the Biggest Management Challenges in Multiple Sclerosis
June 22nd 2019

June Halper Outlines the Biggest Management Challenges in Multiple Sclerosis

The biggest clinical challenges that we have in treating multiple sclerosis are 2-fold, explained June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers.
<1
...
789101112131415
...
21>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo